Rigel Pharmaceuticals Inc (RIGL)

Sales/Maturities of Investments

$143.01M

TTM · Period ending: · USD

RIGL logo

RIGL Sales/Maturities of Investments

Latest reported$143.01M
RIGL Sales/Maturities of Investments ($0.00 → $143.01M)
High-resolution chart · PNG

RIGL sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period endingSales/Maturities of Investments (USD)
61,129,000
39,700,000
41,650,000
101,228,000
62,050,000
130,434,000
123,126,000
104,066,000
96,820,000
128,650,000
196,862,000
281,705,000
382,447,000
439,724,000
415,493,000
216,249,000
139,391,000
170,122,000
127,508,000
89,987,000
89,227,000
72,176,000
6,000,000
47,839,000
29,590,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.